From the Journals

Low-fat diet reduces risk of death if breast cancer is diagnosed


 

FROM THE JOURNAL OF CLINICAL ONCOLOGY

Women can reduce their risk of dying should they receive a breast cancer diagnosis by following a low-fat diet, suggests an analysis from the phase III multicenter randomized Women’s Health Initiative Dietary Modification trial.

Investigators led by Rowan T. Chlebowski, MD, PhD, formerly of the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California, and now at City of Hope National Medical Center, Duarte, California, analyzed data from 48,835 postmenopausal women who had never had breast cancer and had normal mammograms. The women were randomly assigned 2:3 to a diet aimed at reducing fat intake to 20% of energy and increasing intake of fruits, vegetables, and grains or to a usual diet.

Dr. Rowan T. Chlebowski, formerly of the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California, and now at City of Hope National Medical Center, Duarte, California

Dr. Rowan T. Chlebowski

During the median 8.5-year dietary intervention, the rate of deaths attributed to breast cancer was 0.016% per year in the low-fat diet group and 0.024% per year in the usual diet group, a difference that was not significant (P = .08), Dr. Chlebowski and associates reported (J Clin Oncol. 2017 June 27. doi: 10.1200/JCO.2016.72.0326).

However, the rate of deaths after breast cancer from any cause was 0.025% per year in the former group and 0.038% per year in the latter group, a difference that translated to a more than one-third reduction in risk (hazard ratio, 0.65; P = .02).

Similarly, during the median 16.1-year total follow-up, the rate of deaths attributed to breast cancer was 0.035% per year in the low-fat diet group and 0.039% per year in the usual diet group, a difference that was not significant (P =. 41). However, the rate of deaths after breast cancer from any cause was 0.085% per year in the former group and 0.11% per year in the latter group, a difference that translated to a nearly one-fifth reduction in the risk of death (HR, 0.82; P = .01).

In subgroup analyses, there were significant interactions whereby benefit was greater for women who had a baseline waist circumference of at least 88 cm and increased with the baseline percentage of total energy from fat.

“The lower risk of poor prognosis, ER+, PR– breast cancers … in the dietary group contributed to the favorable dietary effect on death after breast cancer,” the investigators noted. “An additional factor that potentially influenced deaths after breast cancer could be a favorable dietary influence on mortality as a result of other causes, including cardiovascular disease.”

“Future studies of other lifestyle interventions on breast cancer incidence and outcome could incorporate some form of a low-fat dietary pattern as a base,” they concluded.

Recommended Reading

Atezolizumab improved survival in triple-negative breast cancer
MDedge Internal Medicine
Physicians favor ACOG mammography recommendations
MDedge Internal Medicine
VIDEO: Dr. Lisa Newman on triple negative breast cancer in African American women
MDedge Internal Medicine
Two new biomarkers show breast cancer validity
MDedge Internal Medicine
Androgen receptor screening not ready for triple-negative breast cancer
MDedge Internal Medicine
Genes may play role in breast cancer racial disparities
MDedge Internal Medicine
More early-stage cancer diagnosis since ACA implementation
MDedge Internal Medicine
Five year survival doubles for younger women with de novo MBC
MDedge Internal Medicine
Breast cancer liquid biopsies don’t change outcomes....yet
MDedge Internal Medicine
ACOG recommends women start mammography between ages 40 and 50 years
MDedge Internal Medicine